Hepatitis C virus lookback: emerging science and public policy

Editorial

J Epstein. Transfusion. 2000 Jan.

. 2000 Jan;40(1):3-5.

doi: 10.1046/j.1537-2995.2000.40010003.x.

No abstract available

Comment on

Use of third-generation hepatitis C virus (HCV) enzyme immunoassay (EIA) to resolve second-generation HCV EIA-reactive and second-generation recombinant immunoblot assay-indeterminate blood samples: data to support current Food and Drug Administration guidance on HCV lookback.
Busch MP, Tobler LH, Tegtmeier G, Polito A, Quan S, Hirschler NV, Dockter J, Giachetti C, Mimms L. Busch MP, et al. Transfusion. 2000 Jan;40(1):10-4. doi: 10.1046/j.1537-2995.2000.40010010.x. Transfusion. 2000. PMID: 10644806 No abstract available.
Lookback on donors who are repeatedly reactive on first-generation hepatitis C virus assays:justification and rational implementation.
Tobler LH, Tegtmeier G, Stramer SL, Quan S, Dockter J, Giachetti C, Busch MP. Tobler LH, et al. Transfusion. 2000 Jan;40(1):15-24. doi: 10.1046/j.1537-2995.2000.40010015.x. Transfusion. 2000. PMID: 10644807